CMMB

Chemomab Therapeutics

9 hedge funds and large institutions have $2.28M invested in Chemomab Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$36.8K
2 +$30K
3 +$25K
4
TRCT
Tower Research Capital (TRC)
New York
+$833

Top Sellers

1 -$448K
2 -$233K
3 -$162K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.6K
5
UBS Group
UBS Group
Switzerland
-$6K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$972K
2
$850K
3
$295K
4
$57K
5
$50K
6
$30K
7
$25K
8
$1K
9
10
11